Grants and Collaborations


Funding

Grant Name

Title

Period

Coordination

EU / Inserm

ERC-INTRACELLTB

A chemical genomics approach of intracellular Mycobacterium tuberculosis towards defining specific host pathogen interactions

12/2010-11/2015

Principal Investigator

EU / Inserm

EU-FP7-MM4TB

More Medicine for Tuberculosis

02/2011-01/2016

Stewart Cole

ANR / Feder /PRES Nord de France

EquipEx ImagIn ExBioMed

High-throughput & ultra-high-content screening microscopy facility

01/2011-01/2019

Frank Lafont

EU / Inserm

CPER Nord Pas de Calais

ERC ‐ INTRACELL‐TB et ImaginEx BioMed

01/2012-03/2016

Principal Investigator

Institut Pasteur / Institut Pasteur de Lille

PTR 441

Identification of Key Molecular Mechanisms of Secretion and Immunogenicity of EspA and EspC Major Virulence Factors of Mycobacterium tuberculosis

10/2013-09/2015

Laleh Majlessi

ANR / CNRS

Infect-ERA HCV-Assembly

Identification of host factors involved in Hepatitis C Virus assembly and

characterization of their potential role in vivo

04/2014-03/2017

Jean Dubuisson

EU / CNRS

EU-ITN-CycloNHit

Nanocarriers for the delivery of antimicrobial agents to fight resistance mechanisms

03/2014-02/2017

Ruxandra Gref

ANR / Institut Pasteur de Lille

ANR-TB-MET

Deciphering the role of metals in mycobacterial virulence & host defence against tuberculosis

10/2014-09/2018

Olivier Neyrolles

ANR / Institut Pasteur de Lille

ANR-ANTI-TB-NANO

“Green” cyclodextrin-based nanoparticles for tuberculosis treatment

10/2014-09/2019

Ruxandra Gref

Sanofi / Institut Pasteur de Lille

Prix Sanofi

Junior Prize

X

Principal Investigator

Institut Pasteur de Lille

Criblage antidouleur

Criblage de la chimiothèque lilloise pour la recherche d’analgésiques

09/2015-09/2016

Coordinator

EMBO / Inserm

EMBO YIP

Pain and Disease: The Mycobacterial Way(s)

01/2016-12/2018

Recipient

ANR / Inserm

TB-EMERG

Birth of a killer: Genetic factors and metabolic adaptations required for the emergence of epidemic tuberculosis bacilli

01/2017-12/2020

Roland Brosch

Institut Pasteur / Institut Pasteur de Lille

PTR 22-16

Reconstitution of Mycobacterium and Shigella infection in physiological condition using organ-in-a-chip

01/2017-12/2019

Nathalie Sauvonnet

ANR / Institut Pasteur de Lille AT2R-Traak-Bioanalgesics Deciphering molecular and cellular pathways in pain control: nature as inspiration for the rational design of new potent analgesics 12/2018-11/2021 Coordinator
I-SITE ULNE / ERC Generator BACIMMUNOMAC Immunometabolic host response against intracellular bacteria: Toward host-directed strategies 12/2018-11/2019 Principal Investigator
CPER / EU / Région Hauts-de-France SALMA-AIEC Automated longitudinal and multi-analytic screening of adherent invasive Escherichia coli strains 12/2018-11/2019 Benoit Foligné
JPI AMR / EU / ANR MTI4MDRTB Development of novel Mycobacterial Tolerance Inhibitors (MTIs) against MDR/XDR tuberculosis 01/03/2019-02/2022 Fredrik Almqvist